Concepedia

Elsy Philip

EP

6

Publications

143

Citations

6

H-Index

2007

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

Covance (United States)

Elsy Philip is an author at Boehringer Ingelheim (United States) specializing in clinical chemistry, medical laboratory science, and drug analysis.

ORCID

Top concepts

Publications per year

2007–2017

6

Publications

6

Development of Immunocapture-LC/MS Assay for Simultaneous ADA Isotyping and Semiquantitation

Linzhi Chen, David Roos, Elsy Philip · Journal of Immunology Research · 2016 · 44 citations · Full text

Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir

Linzhi Chen, John P. Sabo, Elsy Philip et al. · Antimicrobial Agents and Chemotherapy · 2007 · 30 citations · Full text

, , +15

Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers

Linzhi Chen, Arvid Jungnik, Yan‐Ping Mao et al. · Xenobiotica · 2014 · 27 citations

LC–MS Quantification of Protein Drugs: Validating Protein LC–MS Methods with Predigestion Immunocapture

Jeffrey X. Duggan, Bailuo Ren, Yan Mao et al. · Bioanalysis · 2016 · 17 citations

, , +21

Mass Balance, Metabolite Profile, and <i>In Vitro-In Vivo</i> Comparison of Clearance Pathways of Deleobuvir, a Hepatitis C Virus Polymerase Inhibitor

Linzhi Chen, John P. Sabo, Elsy Philip et al. · Antimicrobial Agents and Chemotherapy · 2014 · 13 citations · Full text

Rows per page

1–5 of 6